Indication
Chemotherapy-induced Neuropathic Pain
1 clinical trial
2 products
Clinical trial
A Randomized, Double-Blind, Placebo Controlled, Multicenter, Efficacy and Safety Trial of Single Cycle Tetrodotoxin in the Treatment of Chemotherapy Induced Neuropathic PainStatus: Recruiting, Estimated PCD: 2025-12-01
Product
TetrodotoxinProduct
Placebo